David Tabernero

1.5k total citations
53 papers, 906 citations indexed

About

David Tabernero is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, David Tabernero has authored 53 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 44 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in David Tabernero's work include Hepatitis B Virus Studies (45 papers), Hepatitis C virus research (42 papers) and Liver Disease Diagnosis and Treatment (19 papers). David Tabernero is often cited by papers focused on Hepatitis B Virus Studies (45 papers), Hepatitis C virus research (42 papers) and Liver Disease Diagnosis and Treatment (19 papers). David Tabernero collaborates with scholars based in Spain, Germany and United Kingdom. David Tabernero's co-authors include Francisco Rodríguez‐Frias, Marı́a Buti, Rafael Esteban, María Homs, Josep Quer, Rosendo Jardí, Mélanie Schaper, Mar Riveiro‐Barciela, Josep Gregori and M. Schaper and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Scientific Reports.

In The Last Decade

David Tabernero

52 papers receiving 893 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tabernero Spain 15 747 742 180 82 61 53 906
María Homs Spain 17 765 1.0× 706 1.0× 165 0.9× 53 0.6× 50 0.8× 36 882
Ulrike C. Wend Germany 17 934 1.3× 980 1.3× 171 0.9× 60 0.7× 27 0.4× 28 1.1k
Irmgard Pult Switzerland 10 603 0.8× 670 0.9× 106 0.6× 72 0.9× 40 0.7× 11 809
Jungsuh P. Kim United States 10 549 0.7× 507 0.7× 188 1.0× 42 0.5× 50 0.8× 11 740
Elizabeth Giles Canada 13 469 0.6× 517 0.7× 166 0.9× 57 0.7× 31 0.5× 23 638
Katja Giersch Germany 15 755 1.0× 810 1.1× 159 0.9× 129 1.6× 25 0.4× 39 967
Santiago Dueñas‐Carrera Cuba 17 439 0.6× 380 0.5× 105 0.6× 164 2.0× 30 0.5× 46 655
L. O. Magnius Sweden 8 1.3k 1.7× 1.4k 1.9× 165 0.9× 48 0.6× 90 1.5× 12 1.4k
Damir García‐Cehic Spain 13 195 0.3× 174 0.2× 227 1.3× 99 1.2× 45 0.7× 33 455
Wangdon Yoo South Korea 10 501 0.7× 609 0.8× 223 1.2× 97 1.2× 15 0.2× 19 768

Countries citing papers authored by David Tabernero

Since Specialization
Citations

This map shows the geographic impact of David Tabernero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tabernero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tabernero more than expected).

Fields of papers citing papers by David Tabernero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tabernero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tabernero. The network helps show where David Tabernero may publish in the future.

Co-authorship network of co-authors of David Tabernero

This figure shows the co-authorship network connecting the top 25 collaborators of David Tabernero. A scholar is included among the top collaborators of David Tabernero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tabernero. David Tabernero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodríguez‐Tajes, Sergio, Ariadna Rando‐Segura, Zoe Mariñó, et al.. (2025). HBcrAg and cirB‐RNA Do Not Predict Clinical and Virological Outcomes in Patients With HBeAg‐Negative Chronic Infection. Liver International. 45(5). e70072–e70072.
2.
Gregori, Josep, Damir García‐Cehic, Carolina Campos, et al.. (2024). In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications. Microorganisms. 12(5). 1011–1011. 3 indexed citations
3.
Vila, Marta, David Tabernero, Josep Gregori, et al.. (2024). Genotyping Hepatitis B virus by Next-Generation Sequencing: Detection of Mixed Infections and Analysis of Sequence Conservation. International Journal of Molecular Sciences. 25(10). 5481–5481. 2 indexed citations
4.
Gregori, Josep, Damir García‐Cehic, Mar Riveiro‐Barciela, et al.. (2023). In-Host HEV Quasispecies Evolution Shows the Limits of Mutagenic Antiviral Treatments. International Journal of Molecular Sciences. 24(24). 17185–17185. 3 indexed citations
5.
Roade, Luisa, Mar Riveiro‐Barciela, Maria Pfefferkorn, et al.. (2023). HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriers. JHEP Reports. 5(10). 100842–100842. 2 indexed citations
6.
Quer, Josep, Carolina Campos, Cristina Andrés, et al.. (2022). Next-Generation Sequencing for Confronting Virus Pandemics. Viruses. 14(3). 600–600. 41 indexed citations
7.
Roade, Luisa, Mar Riveiro‐Barciela, Adriana Palom, et al.. (2022). ACE Score Identifies HBeAg-negative Inactive Carriers at a Single-point Evaluation, Regardless of HBV Genotype. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 1 indexed citations
8.
Gregori, Josep, Carolina Campos, Damir García‐Cehic, et al.. (2022). Quasispecies Fitness Partition to Characterize the Molecular Status of a Viral Population. Negative Effect of Early Ribavirin Discontinuation in a Chronically Infected HEV Patient. International Journal of Molecular Sciences. 23(23). 14654–14654. 4 indexed citations
9.
Riveiro‐Barciela, Mar, David Tabernero, Adriana Palom, et al.. (2022). Standardized Hepatitis B Virus RNA Quantification in Untreated and Treated Chronic Patients: a Promising Marker of Infection Follow-Up. Microbiology Spectrum. 10(2). e0214921–e0214921. 6 indexed citations
10.
Tabernero, David, Josep Gregori, Josep Quer, et al.. (2022). Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients. Biomedicines. 10(5). 1194–1194. 2 indexed citations
11.
Tabernero, David, Josep Gregori, Rosario Casillas, et al.. (2022). Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability. Viruses. 14(2). 215–215. 6 indexed citations
12.
Rodríguez‐Frias, Francisco, et al.. (2021). Microorganisms as Shapers of Human Civilization, from Pandemics to Even Our Genomes: Villains or Friends? A Historical Approach. Microorganisms. 9(12). 2518–2518. 10 indexed citations
13.
García‐Cehic, Damir, Ariadna Rando‐Segura, Francisco Rodríguez‐Frias, et al.. (2021). Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure. Journal of Viral Hepatitis. 28(9). 1319–1324. 6 indexed citations
14.
Tabernero, David, et al.. (2021). Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects. Expert Review of Molecular Diagnostics. 21(4). 381–396. 9 indexed citations
15.
Tabernero, David, Josep Gregori, Marta Vila, et al.. (2021). Cross-sectional evaluation of circulating hepatitis B virus RNA and DNA: Different quasispecies?. World Journal of Gastroenterology. 27(41). 7144–7158. 1 indexed citations
16.
Gregori, Josep, Rosario Casillas, Carolina González, et al.. (2020). Conservation and variability of hepatitis B core at different chronic hepatitis stages. World Journal of Gastroenterology. 26(20). 2584–2598. 10 indexed citations
17.
Tabernero, David, et al.. (2018). HDV evolution—will viral resistance be an issue in HDV infection?. Current Opinion in Virology. 32. 100–107. 2 indexed citations
18.
González, Carolina, David Tabernero, Josep Gregori, et al.. (2018). Detection of hyper-conserved regions in hepatitis B virus X gene potentially useful for gene therapy. World Journal of Gastroenterology. 24(19). 2095–2107. 12 indexed citations
19.
Riveiro‐Barciela, Mar, Marı́a Buti, María Homs, et al.. (2014). Cirrhosis, Liver Transplantation and HIV Infection Are Risk Factors Associated with Hepatitis E Virus Infection. PLoS ONE. 9(7). e103028–e103028. 46 indexed citations
20.
Jardí, Rosendo, Francisco Rodríguez‐Frias, Mélanie Schaper, et al.. (2008). Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy. Journal of Hepatology. 49(5). 695–701. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María Homs Breakdown of academic impact, for papers by Ulrike C. Wend Breakdown of academic impact, for papers by Irmgard Pult Breakdown of academic impact, for papers by Jungsuh P. Kim Breakdown of academic impact, for papers by Elizabeth Giles Breakdown of academic impact, for papers by Katja Giersch Breakdown of academic impact, for papers by Santiago Dueñas‐Carrera Breakdown of academic impact, for papers by L. O. Magnius Breakdown of academic impact, for papers by Damir García‐Cehic Breakdown of academic impact, for papers by Wangdon Yoo
Rankless by CCL
2026